Document is current
Any future updates will be listed below
-
Authors
Sahin, Seda https://orcid.org/0000-0002-8233-8659
Ozdilekcan, Cigdem https://orcid.org/0000-0001-5335-0571
Hamurcu, Hayriye Dilek https://orcid.org/0000-0002-1456-2499
Ozlugedik, Samet https://orcid.org/0000-0001-7909-9100
Kaymak, Meric https://orcid.org/0000-0002-4785-5714
Bayhan, Turan https://orcid.org/0000-0001-5793-5606
Sarı, Neriman https://orcid.org/0000-0001-5723-1385
Ilhan, Inci Ergurhan https://orcid.org/0000-0001-6114-3134
-
Funding
Funding for this research was provided by:
Turkish Pediatric Oncology Group (Turkish Pediatric Oncology Group)
Health Sciences University, Dr. Abdurrahman Yurtaslan, Ankara Oncology Training and Research Hospital (Health Sciences University, Dr. Abdurrahman Yurtaslan, Ankara Oncology Training and Research Hospital)
- License Information
-
More Information
Article History
Received: 3 November 2025
Revised: 24 December 2025
Accepted: 21 January 2026
First Online: 14 March 2026
Declarations
:
: This is research involving human participants. The study was conducted in accordance with the current Declaration of Helsinki and the principles of good clinical practice. The ethics committee approval number given by Health Sciences University, Dr. Abdurrahman Yurtaslan, Ankara Oncology Training and Research Hospital, is 2018-11/143.
: Authors have no relationship relevant to this article to disclose.
: Informed consent was obtained from all individual participants included in the study.
: The authors have no relevant financial or non-financial interests to disclose.
